top of page

Our Discovery Collaboration Model

Partners define the target and TPP. CureRX delivers prioritized lead series and supporting data.

CuraGenAI integrates into preclinical workflows to deliver optimization-ready lead series from defined biological targets.

Therapeutics partnering: CuraGen Neuro Therapeutics is open to strategic development and partnering discussions for selected CNS and neuro-oncology programs. Please contact Sharad Agarwal at sharad@curagen.ai.

Contact

Sharad Agarwal, Founder & CEO: sharad@curagen.ai

 

Rory Popert, CBSO: rory@curagen.ai

Phone : +1 732-687-0816

© 2026 CuraGenAI

bottom of page